Request Demo
Last update 25 Oct 2025
Human Growth Hormone (Anhui Anke)
Last update 25 Oct 2025
Overview
Basic Info
Drug Type Biosimilar, Hormone |
Synonyms Somatropin biosimilar (Anhui Anke), 生长激素类似物 (安徽安科), 安苏萌 |
Target |
Action agonists |
Mechanism GHR agonists(Growth hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1999), |
RegulationPriority Review (China) |
Login to view timeline
Structure/Sequence
Sequence Code 26401985
The sequence is quoted from: *****
Related
5
Clinical Trials associated with Human Growth Hormone (Anhui Anke)CTR20211788
评价注射用重组人生长激素用于因软骨发育不全所引起的儿童身材矮小的有效性和安全性的多中心临床试验
[Translation] A multicenter clinical trial to evaluate the efficacy and safety of recombinant human growth hormone for injection in the treatment of short stature in children caused by achondroplasia
CTR20130283
评价注射用重组人生长激素治疗特发性矮小的安全性和有效性的随机、开放、空白对照、多中心临床试验
[Translation] A randomized, open, blank-controlled, multicenter clinical trial to evaluate the safety and efficacy of recombinant human growth hormone for injection in the treatment of idiopathic short stature
CTR20160635
重组人生长激素注射液与注射用重组人生长激素在中国健康成年志愿者中单次给药的生物等效性研究
[Translation] Bioequivalence study of recombinant human growth hormone injection and recombinant human growth hormone for injection after single administration in healthy adult volunteers in China
100 Clinical Results associated with Human Growth Hormone (Anhui Anke)
Login to view more data
100 Translational Medicine associated with Human Growth Hormone (Anhui Anke)
Login to view more data
100 Patents (Medical) associated with Human Growth Hormone (Anhui Anke)
Login to view more data
100 Deals associated with Human Growth Hormone (Anhui Anke)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Idiopathic short stature | China | 13 Sep 2021 | |
| Growth Disorders | China | 05 Feb 2020 | |
| Short Bowel Syndrome | China | 05 Feb 2020 | |
| Noonan Syndrome | China | 01 Jun 2019 | |
| Burns | China | 01 Jan 1999 | |
| Growth hormone deficiency | China | 01 Jan 1999 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Small-for-dates baby | Phase 3 | China | 10 Jun 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free